A recent study by Milasan et al. treated LDLR−/− mice systemically with VEGF-C152S and control solution before the onset of atherosclerosis and reported decreased plaque development in VEGF-C152S-treated mice compared with controls [62]. Here, VEGFA is linked to atherosclerosis.